Literature DB >> 25755607

Epidemiology of hepatocellular carcinoma in India.

Subrat K Acharya1.   

Abstract

Indian data on epidemiology of HCC is not available. Cancer is not a reportable disease in India and the cancer registries in India are mostly urban. National cancer registry program of the Indian Council of Medical Research (ICMR) has been recently expanded to include 21 population based and 6 hospital based cancer registries. The last published registry data by ICMR available in the cancer registry website (www.ncrpindia.org) was in 2008 which provides information on various cancers from 2006 to 2008. The other source of information was the report published by International Agency for Research on Cancer (WHO). According to these available data the age adjusted incidence rate of hepatocellular carcinoma (HCC) in India for men ranges from 0.7 to 7.5 and for women 0.2 to 2.2 per 100,000 population per year. The male:female ratio for HCC in India is 4:1. The age of presentation varies from 40 to 70 years. According to a study conducted by verbal autopsy in 1.1 million homes representing the whole country, the age standardized mortality rate for HCC in India for men is 6.8/100,000 and for women is 5.1/100,000. According to another study the incidence of HCC in cirrhotics in India is 1.6% per year. The unpublished data from various tertiary care centers suggest that the incidence of HCC is increasing in India. There is a need for a multi-centric HCC registry under the aegis of INASL.

Entities:  

Keywords:  AAIR, age adjusted incidence rate; ASMR, age standardized mortality rate; HBCR, hospital based cancer registry; HCC; HCC, hepatocellular carcinoma; IARC, international agency for cancer research; ICMR, Indian Council of Medical Research; India; PBCR, population based cancer registry; epidemiology

Year:  2014        PMID: 25755607      PMCID: PMC4284206          DOI: 10.1016/j.jceh.2014.05.013

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  17 in total

1.  Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India.

Authors:  Shashi B Paul; Sreenivasa Baba Chalamalasetty; Sreenivas Vishnubhatla; Kaushal Madan; Shivanand R Gamanagatti; Yogesh Batra; Siddhartha D Gupta; Subrat K Panda; Subrat K Acharya
Journal:  Oncology       Date:  2009-07-28       Impact factor: 2.935

2.  Surveillance of Indians with liver cirrhosis for treatable hepatocellular carcinoma: another enigma.

Authors:  K M Mohandas
Journal:  Indian J Gastroenterol       Date:  2007 Nov-Dec

3.  Comparison of 7 staging systems in north Indian cohort of hepatocellular carcinoma.

Authors:  Sanjay Sarma; Balkrishan Sharma; Yogesh Kumar Chawla; Shweta Kapil; Bhupesh Singla; Naveen Kalra; Arunashu Behera; Ajay Duseja; Radha Krishan Dhiman
Journal:  Trop Gastroenterol       Date:  2010 Oct-Dec

4.  Cancer mortality in India: a nationally representative survey.

Authors:  Rajesh Dikshit; Prakash C Gupta; Chinthanie Ramasundarahettige; Vendhan Gajalakshmi; Lukasz Aleksandrowicz; Rajendra Badwe; Rajesh Kumar; Sandip Roy; Wilson Suraweera; Freddie Bray; Mohandas Mallath; Poonam K Singh; Dhirendra N Sinha; Arun S Shet; Hellen Gelband; Prabhat Jha
Journal:  Lancet       Date:  2012-03-28       Impact factor: 79.321

Review 5.  Hepatocellular carcinoma in cirrhosis: incidence and risk factors.

Authors:  Giovanna Fattovich; Tommaso Stroffolini; Irene Zagni; Francesco Donato
Journal:  Gastroenterology       Date:  2004-11       Impact factor: 22.682

6.  Profile of hepatocellular carcinoma in India: an insight into the possible etiologic associations.

Authors:  S K Sarin; V Thakur; R C Guptan; S Saigal; V Malhotra; S P Thyagarajan; B C Das
Journal:  J Gastroenterol Hepatol       Date:  2001-06       Impact factor: 4.029

Review 7.  Surveillance of cirrhosis for hepatocellular carcinoma: systematic review and economic analysis.

Authors:  J Thompson Coon; G Rogers; P Hewson; D Wright; R Anderson; M Cramp; S Jackson; S Ryder; A Price; K Stein
Journal:  Health Technol Assess       Date:  2007-09       Impact factor: 4.014

Review 8.  Sytematic review and meta-analysis of prevalence of hepatitis B in India.

Authors:  Ashish Batham; Dherian Narula; Tanmay Toteja; V Sreenivas; Jacob M Puliyel
Journal:  Indian Pediatr       Date:  2007-09       Impact factor: 1.411

9.  Incidence of hepatocellular carcinoma among Indian patients with cirrhosis of liver: an experience from a tertiary care center in northern India.

Authors:  Shashi Bala Paul; Vishnubhatla Sreenivas; Manpreet Singh Gulati; Kaushal Madan; Arun Kumar Gupta; Sima Mukhopadhyay; Subrat Kumar Panda; Subrat Kumar Acharya
Journal:  Indian J Gastroenterol       Date:  2007 Nov-Dec

10.  Trends in cancer incidence in esophagus, stomach, colon, rectum and liver in males in India.

Authors:  Balkrishna B Yeole
Journal:  Asian Pac J Cancer Prev       Date:  2008 Jan-Mar
View more
  22 in total

Review 1.  Genomic Medicine and Implications for Hepatocellular Carcinoma Prevention and Therapy.

Authors:  Renumathy Dhanasekaran; Jean-Charles Nault; Lewis R Roberts; Jessica Zucman-Rossi
Journal:  Gastroenterology       Date:  2018-11-04       Impact factor: 22.682

2.  Differentially expressed serum host proteins in hepatitis B and C viral infections.

Authors:  Kruti Dalal; Priyanka Khorate; Bhavik Dalal; Rahul Chavan; Shobna Bhatia; Avinash Kale; Akash Shukla; Aruna Shankarkumar
Journal:  Virusdisease       Date:  2018-09-01

3.  Hepatobiliary quiz-12 (2014).

Authors:  Swastik Agrawal; Radha K Dhiman
Journal:  J Clin Exp Hepatol       Date:  2014-12

Review 4.  Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update.

Authors:  Masao Omata; Ann-Lii Cheng; Norihiro Kokudo; Masatoshi Kudo; Jeong Min Lee; Jidong Jia; Ryosuke Tateishi; Kwang-Hyub Han; Yoghesh K Chawla; Shuichiro Shiina; Wasim Jafri; Diana Alcantara Payawal; Takamasa Ohki; Sadahisa Ogasawara; Pei-Jer Chen; Cosmas Rinaldi A Lesmana; Laurentius A Lesmana; Rino A Gani; Shuntaro Obi; A Kadir Dokmeci; Shiv Kumar Sarin
Journal:  Hepatol Int       Date:  2017-06-15       Impact factor: 6.047

Review 5.  Joint Consensus Statement of the Indian National Association for Study of the Liver and Indian Radiological and Imaging Association for the Diagnosis and Imaging of Hepatocellular Carcinoma Incorporating Liver Imaging Reporting and Data System.

Authors:  Sonal Krishan; Radha K Dhiman; Navin Kalra; Raju Sharma; Sanjay S Baijal; Anil Arora; Ajay Gulati; Anu Eapan; Ashish Verma; Shyam Keshava; Amar Mukund; S Deva; Ravi Chaudhary; Karthick Ganesan; Sunil Taneja; Ujjwal Gorsi; Shivanand Gamanagatti; Kumble S Madhusudan; Pankaj Puri; Shallini Govil; Manav Wadhavan; Sanjiv Saigal; Ashish Kumar; Shallini Thapar; Ajay Duseja; Neeraj Saraf; Anubhav Khandelwal; Sumit Mukhopadyay; Ajay Gulati; Nitin Shetty; Nipun Verma
Journal:  J Clin Exp Hepatol       Date:  2019-08-06

6.  Survival and Outcome in Patients Receiving Drug-Eluting Beads Transarterial Chemoembolization for Large Hepatocellular Carcinoma (>5 cm).

Authors:  Amar Mukund; Krishna Bhardwaj; Ashok Choudhury; Shiv K Sarin
Journal:  J Clin Exp Hepatol       Date:  2021-02-15

7.  Current practices in management of hepatocellular carcinoma in India: results of an online survey.

Authors:  Ashish Kumar
Journal:  J Clin Exp Hepatol       Date:  2014-07-23

8.  New Developments in the Treatment of Hepatocellular Carcinoma: The Concept of Adjuvant and Neoadjuvant Chemotherapy.

Authors:  Anil C Anand; Subrat K Acharya
Journal:  J Clin Exp Hepatol       Date:  2021-04-27

9.  Role of N-acetyl Cysteine in Post-transarterial Chemoembolization Transaminitis in Hepatocellular Carcinoma: A Single-center Experience.

Authors:  Chandan K Kedarisetty; Sipra Bal; Subhashree Parida; Mayank Jain; Ajeet S Bhadoria; Joy Varghese; Jayanthi Venkataraman
Journal:  J Clin Exp Hepatol       Date:  2020-10-27

Review 10.  Should We Treat Immune Tolerant Chronic Hepatitis B? Lessons from Asia.

Authors:  Madhumita Premkumar; Yogesh K Chawla
Journal:  J Clin Exp Hepatol       Date:  2021-08-27
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.